Pyrogenesis Canada Inc
Change company Symbol lookup
Select an option...
PYR Pyrogenesis Canada Inc
CHRA Charah Solutions Inc
FTIIU Futuretech II Acquisition Corp
JBL Jabil Inc
AZO Autozone Inc
SBFFF SBM Offshore NV
ALHC Alignment Healthcare Inc
PRGS Progress Software Corp
PMD Psychemedics Corp
RPHM Reneo Pharmaceuticals Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Industrials : Commercial Services & Supplies | Small Cap Blend
Based in Canada
Company profile

PyroGenesis Canada Inc. is a Canada-based technology company. The Company is engaged in the design, development, manufacture and commercialization of advanced plasma processes and sustainable solutions, which reduce greenhouse gases. Its products and services include Plasma Atomized Metal Powders, Aluminum and Zinc Dross Recovery: DROSRITE, waste management, plasma torches, and Innovation / Custom Process Development, among others. It offers products across various industries. The Company provides engineering and manufacturing expertise, contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, additive manufacturing, including three-dimensional (3D) printing, oil and gas, and environmental industries. It provides plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. It offers technologies, equipment, and expertise in biogas upgrading, and air pollution control.

Closing Price
$0.81
Day's Change
-0.07 (-7.95%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.8673
Day's Low
0.7834
Volume
(Heavy Day)
Volume:
122,395

10-day average volume:
49,310
122,395

Bristol Myers Squibb Co. Stock Falls Tuesday, Underperforms Market

4:42 pm ET January 17, 2023 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bristol Myers Squibb Co. (BMY) slipped 0.28% to $72.31 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.20% to 3,990.97 and Dow Jones Industrial Average falling 1.14% to 33,910.85. Bristol Myers Squibb Co. closed $9.13 short of its 52-week high ($81.44), which the company reached on December 1st.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) fell 0.62% to $172.36, Pfizer Inc. (PFE) fell 3.70% to $46.08, and Abbott Laboratories (ABT) fell 0.11% to $113.39. Trading volume (8.9 M) remained 128,201 below its 50-day average volume of 9.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 17, 2023.

	

(END) Dow Jones Newswires

January 17, 2023 16:42 ET (21:42 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.